Skip to content

VYANT BIO, INC: 10-Q filed 2013-08-05

What VYANT BIO, INC reported in its quarterly report filed 2013-08-05 (fiscal Q2 2013): 36 published measures, 107 facts as tagged in accession 0001193125-13-318286.

This filing

Form
10-Q (quarterly report)
Filed
2013-08-05
Fiscal period
fiscal Q2 2013
Accession
0001193125-13-318286 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VYANT BIO, INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-06-306,455,584USD
At 2012-12-318,951,771USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-06-3013,324,190USD
At 2012-12-3132,933,167USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-06-30-6,868,606USD
At 2012-12-31-23,981,396USD
At 2012-06-30-20,813,671USD
At 2011-12-31-19,065,357USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-06-301,940,808USD
At 2012-12-31819,906USD
At 2012-06-30401,545USD
At 2011-12-312,417,256USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-9,142,191USD91
2013-01-01 to 2013-06-30-6,781,788USD181
2012-04-01 to 2012-06-30-1,860,461USD91
2012-01-01 to 2012-06-30-2,932,978USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-3,746,739USD181
2012-01-01 to 2012-06-30-4,101,685USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-06-3042,576USD181
2012-01-01 to 2012-06-3027,333USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-04-01 to 2013-06-301,831,649USD91
2013-01-01 to 2013-06-303,050,316USD181
2012-04-01 to 2012-06-301,148,475USD91
2012-01-01 to 2012-06-301,983,227USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-06-305,010,985USD181
2012-01-01 to 2012-06-302,312,307USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-143,344USD181
2012-01-01 to 2012-06-30-226,333USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-06-30-55,733,815USD
At 2012-12-31-48,934,585USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-04-01 to 2013-06-303,985,663shares91
2013-01-01 to 2013-06-302,682,442shares181
2012-04-01 to 2012-06-301,346,124shares91
2012-01-01 to 2012-06-301,337,702shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-04-01 to 2013-06-303,985,663shares91
2013-01-01 to 2013-06-302,682,442shares181
2012-04-01 to 2012-06-301,429,735shares91
2012-01-01 to 2012-06-301,421,313shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-2.29USD/shares91
2013-01-01 to 2013-06-30-2.53USD/shares181
2012-04-01 to 2012-06-30-1.38USD/shares91
2012-01-01 to 2012-06-30-2.19USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-2.29USD/shares91
2013-01-01 to 2013-06-30-4.44USD/shares181
2012-04-01 to 2012-06-30-2.32USD/shares91
2012-01-01 to 2012-06-30-4.2USD/shares182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-663,900USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-06-30856,433USD
At 2012-12-31964,923USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-04-01 to 2013-06-30172,734USD91
2013-01-01 to 2013-06-30215,219USD181
2012-04-01 to 2012-06-30287,817USD91
2012-01-01 to 2012-06-30564,684USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-1,733,786USD91
2013-01-01 to 2013-06-30-4,042,904USD181
2012-04-01 to 2012-06-30-2,233,664USD91
2012-01-01 to 2012-06-30-4,021,200USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-06-303,893,874USD
At 2012-12-312,159,729USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-04-01 to 2013-06-30389,319USD91
2013-01-01 to 2013-06-301,683,308USD181
2012-04-01 to 2012-06-301,082,797USD91
2012-01-01 to 2012-06-301,947,778USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-06-3012,638,647USD
At 2012-12-3111,771,696USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-06-301,263,241USD
At 2012-12-31850,545USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-04-01 to 2013-06-302,286,161USD91
2013-01-01 to 2013-06-304,743,926USD181
2012-04-01 to 2012-06-302,296,506USD91
2012-01-01 to 2012-06-304,095,742USD182

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-04-01 to 2013-06-30552,375USD91
2013-01-01 to 2013-06-30701,022USD181
2012-04-01 to 2012-06-3062,842USD91
2012-01-01 to 2012-06-3074,542USD182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2013-04-01 to 2013-06-301,279,274USD91
2013-01-01 to 2013-06-302,349,294USD181
2012-04-01 to 2012-06-301,085,633USD91
2012-01-01 to 2012-06-301,908,685USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-04-01 to 2013-06-30455,570USD91
2013-01-01 to 2013-06-30950,597USD181
2012-04-01 to 2012-06-30526,730USD91
2012-01-01 to 2012-06-301,050,241USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-06-304,316,691shares
At 2012-12-311,349,936shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-06-3048,864,777USD
At 2012-12-3124,970,255USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-06-301,705,277USD
At 2012-12-315,827,119USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-9,142,191USD91
2013-01-01 to 2013-06-30-11,910,788USD181
2012-04-01 to 2012-06-30-3,316,461USD91
2012-01-01 to 2012-06-30-5,968,978USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-301,384,123USD91
2013-01-01 to 2013-06-302,961,374USD181
2012-04-01 to 2012-06-301,393,495USD91
2012-01-01 to 2012-06-302,329,652USD182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-06-30151,066USD181
2012-01-01 to 2012-06-30173,496USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-7,408,405USD91
2013-01-01 to 2013-06-30-3,402,784USD181
2012-04-01 to 2012-06-30373,203USD91
2012-01-01 to 2012-06-301,088,222USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2013-01-01 to 2013-06-30489,509USD181
2012-01-01 to 2012-06-30484,936USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-30412,696USD181
2012-01-01 to 2012-06-3043,211USD182

Inspect the source

Entity
VYANT BIO, INC / CIK 0001349929
Captured
SEC response SHA-256
7d91e6e73e65644a3ee9e03c19e7466c093ccc564c8f47ac2e6a9c101f9652fb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001349929.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))